Ostatní
Návod 
ICU Medical, Inc.
ICUI
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
3.5B
Obrat
2B
Zisk
0B
Aktiva
4B
Dluh
1B
ROE
0%
ROA
0%
PE
4228
PS
1
Cena 1R
107-176
⌀ Cena
132.99
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda
Profil
Společnost ICU Medical, Inc. společně se svými dceřinými společnostmi vyvíjí, vyrábí a prodává zdravotnické prostředky používané v aplikacích infuzní terapie a kritické péče po celém světě. Výrobky společnosti pro infuzní terapii zahrnují výrobky bez jehel pod značkami MicroClave, MicroClave Clear a NanoClave; neutronové katetrové patentové přístroje; SwabCap a SwabTip dezinfekční čepice; Tego hemodialyzační konektory; ClearGuard HD, antimikrobiální bariérové víčko pro hemodialyzační katétry; a uzavřené systémy ChemoClave a ChemoLock, stejně jako systém Diana pro přípravu nebezpečných léků. Poskytuje také IV terapii a ředidla, jako je chlorid sodný, dextróza, vyvážené roztoky elektrolytů, laktátové ringery, ringer's, mannitol, chlorid sodný/dextróza a sterilní voda; a zavlažování zahrnující chlorid sodný a sterilní vody zavlažování, fyziologické roztoky, ringer je zavlažování, zavlažování kyseliny octové, glycin zavlažování, sorbitol-mannitol zavlažování, flexibilní nádoby a lijte lahve. Společnost nabízí infuzní pumpy pod značkami Plum 360 a LifeCare PCA; IV mediační bezpečnostní software, včetně ICU Medical MedNet, platformu pro řízení léků třídy enterprise-class, která spojuje inteligentní pumpy s elektronickými zdravotními záznamy nemocnice, systémy sledování majetku a oznamovacími platformami pro poplašné systémy; a související profesionální služby. Poskytuje také produkty kritické péče, jako jsou systémy sledování hemodynamických procesů Cogent 2-in-1 a CardioFlo, katétry pro sledování srdečního výdeje TDQ a OptiQ, katétry pro sledování žilní oximetrie TriOx, transplantační snímače krevního tlaku a uzavřené systémy pro odběr a konzervaci krve SafeSet. Společnost prodává své produkty nemocnicím akutní péče, velkoobchodníkům, ambulantním klinikám a alternativním místním zařízením, včetně ambulantních klinik, domácích poskytovatelů zdravotní péče a zařízení dlouhodobé péče. ICU Medical, Inc. byla založena v roce 1984 a sídlí v San Clemente v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
15000
Založení
1992-03-31
Podobné společnosti
$ 24.00
- $ 0.23
$ 11.02
- $ 0.16
$ 60.25
+ $ 0.30
$ 70.80
+ $ 2.44
$ 50.78
+ $ 0.33
$ 33.60
+ $ 1.26
$ 14.39
- $ 0.06
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 2,230.9 | 2,230.0 | 2,382.0 | 2,259.1 | 2,280.0 | 1,316.3 | 1,271.0 | 1,266.2 | 1,400.0 | 1,292.6 | 379.4 | 341.7 | 309.3 | 313.7 | 316.9 | 302.2 | 284.6 | |
| Cost of Revenues | 1,409.7 | 1,410.4 | 1,557.3 | 1,519.3 | 1,582.2 | 824.8 | 809.5 | 794.3 | 830.0 | 866.5 | 178.0 | 160.9 | 157.9 | 159.0 | 160.4 | 159.8 | 154.0 | |
| Gross Profit | 821.2 | 819.7 | 824.8 | 739.9 | 697.8 | 491.5 | 461.5 | 471.9 | 570.0 | 426.1 | 201.4 | 180.8 | 151.4 | 154.7 | 156.5 | 142.4 | 130.6 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 540.3 | 537.0 | 548.9 | 604.7 | 629.8 | 589.1 | 596.5 | 566.7 | 588.0 | 553.3 | |
| Cost of Revenues | 338.2 | 336.1 | 340.8 | 394.6 | 402.5 | 384.3 | 389.0 | 381.4 | 430.2 | 369.4 | |
| Gross Profit | 202.1 | 200.9 | 208.1 | 210.1 | 227.3 | 204.9 | 207.4 | 185.2 | 157.8 | 183.9 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 85.3 | 93.0 | 47.5 | 42.9 | 48.6 | 52.9 | 51.3 | 13.0 | 15.7 | 18.3 | 12.4 | 10.6 | 8.6 | 4.7 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 606.7 | 608.3 | 302.6 | 284.0 | 277.0 | 328.1 | 304.0 | 89.4 | 83.2 | 88.9 | 90.4 | 84.6 | 85.3 | 76.6 | |
| Depreciation & Amortization | 204.3 | 218.0 | 2.4 | 228.8 | 235.2 | 89.7 | 94.8 | 85.2 | 74.7 | 66.6 | 19.1 | 18.1 | 19.4 | 19.5 | 19.0 | 18.3 | 17.3 | |
| Total Operating Expenses | 758.8 | 712.7 | 781.8 | 717.0 | 701.3 | 350.2 | 325.9 | 331.3 | 381.0 | 355.2 | 102.4 | 98.9 | 107.3 | 102.8 | 95.2 | 93.9 | 81.3 | |
| Operating Income | 62.4 | 107.0 | 43.0 | 22.8 | -8.7 | 52.4 | 41.8 | 63.2 | 21.6 | -15.1 | 82.9 | 68.6 | 39.0 | 51.9 | 61.3 | 65.2 | 49.3 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 22.4 | 20.9 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 154.6 | 148.6 | ||
| Depreciation & Amortization | 54.3 | 50.8 | 49.7 | 49.4 | 53.0 | 55.6 | 55.3 | 55.5 | 62.5 | 273.7 | ||
| Total Operating Expenses | 176.9 | 187.2 | 197.5 | 197.2 | 189.6 | 196.6 | 199.7 | 195.9 | 177.0 | 169.5 | ||
| Operating Income | 25.2 | 13.7 | 10.6 | 12.9 | 37.7 | 8.2 | 7.7 | -10.7 | -19.2 | 22.9 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 7.9 | 10.3 | 10.8 | 7.5 | 4.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 96.7 | 105.4 | 106.5 | 102.7 | 66.4 | 0.9 | 1.8 | 0.5 | 0.7 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -59.3 | -103.8 | -109.0 | -101.1 | -105.7 | 70.8 | 55.7 | 51.5 | -165.9 | -17.6 | -13.9 | -12.2 | -4.3 | 0.8 | 0.6 | 17.9 | 0.1 | |
| IBT | 3.2 | 3.2 | -66.0 | -78.3 | -114.4 | 123.2 | 97.5 | 114.7 | 22.4 | 51.3 | 85.2 | 69.7 | 39.8 | 52.7 | 61.8 | 66.4 | 49.4 | |
| Income Tax Expense | 2.4 | 2.4 | 51.7 | -48.6 | -40.1 | 20.1 | 10.6 | 13.7 | -6.4 | -17.4 | 22.1 | 24.7 | 13.5 | 12.3 | 20.6 | 21.8 | 18.5 | |
| Net Income | 0.7 | 0.7 | -117.7 | -29.7 | -74.3 | 103.1 | 86.9 | 101.0 | 28.8 | 68.6 | 63.1 | 45.0 | 26.3 | 40.4 | 41.3 | 44.7 | 30.9 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 2.1 | 0.0 | 2.5 | 3.2 | 2.7 | 2.6 | 2.8 | 2.6 | 2.3 | 1.7 | ||
| Interest Expense | 24.8 | 19.8 | 23.1 | 29.0 | 26.2 | 27.3 | 26.6 | 26.4 | 33.0 | 24.2 | ||
| Other Expense | -43.6 | -17.8 | 25.9 | -23.8 | -29.5 | -26.2 | -27.2 | -26.1 | -24.5 | -28.2 | ||
| IBT | -18.4 | -4.1 | 36.5 | -10.9 | 8.2 | -17.9 | -19.5 | -36.8 | -36.7 | -5.4 | ||
| Income Tax Expense | -2.7 | -0.7 | 1.2 | 4.6 | 32.0 | 15.1 | 1.9 | 2.7 | -19.5 | -12.6 | ||
| Net Income | -15.7 | -3.4 | 35.3 | -15.5 | -23.8 | -33.0 | -21.4 | -39.5 | -17.1 | 7.2 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.23 | $-3.11 | $4.86 | $4.16 | $4.90 | $1.41 | $3.50 | $3.90 | $2.84 | $1.72 | $2.75 | $2.90 | $3.23 | $2.20 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.23 | $-3.11 | $4.74 | $4.02 | $4.69 | $1.33 | $3.29 | $3.66 | $2.73 | $1.68 | $2.65 | $2.80 | $3.15 | $2.16 | |
| Shares Outstanding | 24.7 | 24.6 | 24.4 | 24.1 | 23.9 | 21.2 | 20.9 | 20.6 | 20.4 | 19.6 | 16.2 | 15.8 | 15.3 | 14.7 | 14.2 | 13.8 | 13.6 | |
| Diluted Shares Outstanding | 24.7 | 24.9 | 24.4 | 24.1 | 23.9 | 21.8 | 21.6 | 21.5 | 21.6 | 20.9 | 17.3 | 16.5 | 15.6 | 15.3 | 14.7 | 14.2 | 13.9 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.71 | $0.30 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.71 | $0.30 | ||
| Shares Outstanding | 24.7 | 24.7 | 24.6 | 24.5 | 24.5 | 24.4 | 24.4 | 24.2 | 24.1 | 24.1 | ||
| Diluted Shares Outstanding | 24.7 | 24.7 | 24.7 | 24.5 | 24.5 | 24.4 | 24.4 | 24.2 | 24.1 | 24.4 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 302.6 | 308.6 | 254.2 | 208.8 | 552.8 | 396.1 | 268.7 | 344.8 | 290.1 | 445.1 | 336.2 | 275.8 | 226.0 | 146.9 | 99.6 | 78.9 | |
| Short Term Investments | 302.6 | 0.0 | 0.5 | 4.2 | 14.4 | 14.7 | 24.0 | 37.3 | 10.1 | 445.1 | 41.2 | 71.0 | 70.9 | 79.3 | 60.4 | 14.5 | |
| Total Cash & ST Investments | 302.6 | 308.6 | 254.7 | 213.0 | 567.2 | 410.8 | 292.6 | 382.1 | 300.1 | 445.1 | 377.4 | 346.8 | 296.9 | 226.2 | 160.0 | 93.4 | |
| Accounts Receivable | 154.9 | 202.7 | 182.1 | 221.7 | 105.9 | 124.1 | 202.2 | 196.4 | 219.6 | 56.2 | 57.8 | 39.1 | 45.3 | 49.1 | 47.7 | 55.1 | |
| Inventory | 682.9 | 584.7 | 709.4 | 696.0 | 290.2 | 314.9 | 337.6 | 311.2 | 288.7 | 49.3 | 43.6 | 36.9 | 34.5 | 36.3 | 40.4 | 44.1 | |
| Other Current Assets | 90.5 | 346.0 | 75.0 | 88.9 | 2.2 | 1.8 | 4.4 | 1.5 | 3.1 | 18.6 | 26.1 | 14.5 | 17.6 | 13.9 | 16.4 | 15.3 | |
| Total Current Assets | 1,231.0 | 1,442.0 | 1,221.3 | 1,235.2 | 1,029.8 | 920.8 | 882.2 | 927.0 | 864.7 | 569.1 | 505.0 | 437.2 | 394.3 | 325.5 | 263.0 | 207.8 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 299.7 | 300.0 | 289.7 | 308.6 | 312.5 | 302.6 | 251.4 | 254.2 | 197.2 | 195.9 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 1.8 | 1.8 | |
| Total Cash & ST Investments | 299.7 | 300.0 | 289.7 | 308.6 | 312.5 | 302.6 | 251.4 | 254.7 | 199.0 | 197.7 | |
| Accounts Receivable | 217.2 | 219.2 | 204.7 | 202.7 | 198.8 | 154.9 | 169.0 | 182.1 | 161.8 | 162.2 | |
| Inventory | 622.4 | 616.5 | 590.3 | 584.7 | 692.0 | 682.9 | 693.0 | 709.4 | 759.6 | 775.3 | |
| Other Current Assets | 67.9 | 44.4 | 339.2 | 346.0 | 54.7 | 95.5 | 74.3 | 75.0 | 98.2 | 111.7 | |
| Total Current Assets | 1,207.3 | 1,180.1 | 1,423.9 | 1,442.0 | 1,258.1 | 1,236.0 | 1,187.7 | 1,219.6 | 1,219.4 | 1,244.7 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 663.8 | 499.3 | 685.5 | 711.0 | 508.2 | 513.2 | 490.6 | 432.6 | 398.7 | 85.7 | 74.3 | 86.1 | 87.9 | 85.9 | 83.0 | 83.5 | |
| Goodwill | 1,450.9 | 1,432.8 | 1,472.4 | 1,449.3 | 43.4 | 33.0 | 31.2 | 11.2 | 12.4 | 5.6 | 6.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | |
| Intangible Assets | 805.8 | 740.8 | 870.6 | 982.8 | 188.3 | 197.2 | 211.4 | 133.4 | 143.8 | 22.4 | 23.9 | 7.1 | 8.5 | 10.0 | 11.4 | 14.8 | |
| Long-Term Investments | 38.4 | 8.8 | 3.1 | 0.5 | 4.6 | 13.0 | 0.0 | 2.0 | 14.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 57.9 | 56.1 | 88.2 | 105.5 | 63.7 | 55.5 | 49.0 | 40.4 | 38.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Long-Term Assets | 3,055.7 | 2,761.9 | 3,157.2 | 3,280.4 | 850.9 | 842.9 | 810.2 | 658.4 | 632.3 | 135.6 | 121.8 | 103.9 | 105.3 | 103.0 | 100.7 | 104.4 | |
| Total Assets | 4,286.7 | 4,203.9 | 4,378.4 | 4,515.6 | 1,880.7 | 1,763.7 | 1,692.4 | 1,585.4 | 1,497.0 | 704.7 | 626.8 | 541.1 | 499.6 | 428.5 | 363.7 | 312.2 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 512.6 | 511.3 | 503.3 | 499.3 | 658.5 | 663.8 | 670.1 | 682.8 | 682.5 | 692.6 | |
| Goodwill | 1,498.8 | 1,501.9 | 1,455.1 | 1,432.8 | 1,478.3 | 1,450.9 | 1,459.4 | 1,472.4 | 1,444.5 | 1,464.5 | |
| Intangible Assets | 664.8 | 698.0 | 716.7 | 740.8 | 785.8 | 805.8 | 836.9 | 870.6 | 891.3 | 929.8 | |
| Long-Term Investments | 134.1 | 131.6 | 3.0 | 3.0 | 3.1 | 12.7 | 3.1 | 39.3 | 3.1 | 3.2 | |
| Other Long-Term Assets | 61.4 | 61.3 | 58.3 | 61.8 | 80.6 | 78.6 | 91.0 | 56.4 | 104.6 | 96.8 | |
| Total Long-Term Assets | 2,895.6 | 2,927.3 | 2,760.7 | 2,761.9 | 3,047.0 | 3,050.7 | 3,100.7 | 3,158.8 | 3,157.5 | 3,218.3 | |
| Total Assets | 4,102.9 | 4,107.4 | 4,184.6 | 4,203.9 | 4,305.0 | 4,286.7 | 4,288.4 | 4,378.4 | 4,376.9 | 4,463.0 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 155.5 | 148.0 | 150.0 | 215.9 | 81.1 | 71.9 | 128.6 | 120.5 | 78.2 | 14.6 | 13.7 | 11.4 | 11.3 | 11.3 | 13.3 | 10.9 | |
| Short-Term Debt | 69.9 | 66.7 | 71.2 | 29.7 | 9.0 | 8.7 | 7.4 | 6.2 | 9.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 252.7 | 299.9 | 214.5 | 218.1 | 98.0 | 109.3 | 105.8 | 118.9 | 119.7 | 25.9 | 28.9 | 17.4 | 15.6 | 17.8 | 16.1 | 14.6 | |
| Current Liabilities | 511.9 | 556.2 | 481.8 | 494.6 | 200.8 | 195.5 | 248.5 | 249.3 | 210.3 | 40.5 | 42.6 | 28.7 | 26.9 | 29.1 | 29.3 | 25.8 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 171.8 | 168.8 | 180.4 | 148.0 | 168.6 | 155.5 | 152.5 | 150.0 | 149.3 | 167.1 | |
| Short-Term Debt | 0.0 | 0.0 | 61.3 | 66.7 | 68.1 | 69.9 | 69.5 | 72.0 | 66.4 | 59.6 | |
| Other Current Liabilities | 287.2 | 291.9 | 255.4 | 299.9 | 271.4 | 248.5 | 189.4 | 213.7 | 208.1 | 209.6 | |
| Current Liabilities | 492.9 | 482.8 | 549.0 | 556.2 | 549.6 | 511.9 | 455.4 | 481.8 | 464.0 | 483.9 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1,554.8 | 1,575.0 | 1,632.7 | 1,623.7 | 36.0 | 43.4 | 28.9 | -10.8 | 6.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 54.6 | 58.8 | 75.1 | 80.9 | 45.0 | 52.1 | 36.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 53.8 | 48.8 | 55.9 | 126.0 | 1.5 | 1.7 | 2.1 | 0.7 | 1.5 | 1.4 | 1.4 | 1.4 | 3.6 | 5.2 | 7.1 | 8.0 | |
| Total Liabilities | 2,248.9 | 2,238.7 | 2,255.0 | 2,425.7 | 264.7 | 261.4 | 315.1 | 321.7 | 298.7 | 44.5 | 47.0 | 32.9 | 34.9 | 37.7 | 40.5 | 37.9 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1,364.5 | 1,390.2 | 1,539.1 | 1,575.0 | 1,590.9 | 1,609.4 | 1,617.7 | 1,632.7 | 1,648.5 | 1,662.7 | |
| Capital Leases | 50.6 | 52.5 | 64.0 | 58.8 | 64.7 | 72.5 | 69.9 | 54.9 | 79.1 | 81.2 | |
| Def. Tax Liability | 41.4 | 43.2 | 45.5 | 48.8 | 48.5 | 53.8 | 55.6 | 55.9 | 77.8 | 89.7 | |
| Total Liabilities | 1,975.6 | 1,991.6 | 2,196.9 | 2,238.7 | 2,256.5 | 2,248.9 | 2,220.6 | 2,255.0 | 2,278.5 | 2,348.2 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 2.4 | 2.5 | 2.4 | 2.4 | 2.1 | 2.1 | 2.1 | 2.0 | 2.0 | 1.6 | 1.6 | 1.6 | 1.5 | 1.5 | 1.5 | 1.5 | |
| Retained Earnings | 747.0 | 690.2 | 807.8 | 837.5 | 911.8 | 808.7 | 721.8 | 620.7 | 585.6 | 517.0 | 453.9 | 408.9 | 382.6 | 342.2 | 303.5 | 258.8 | |
| Comprehensive Income | -91.8 | -139.4 | -53.1 | -81.0 | -19.3 | -1.5 | -15.4 | -16.9 | -15.0 | -21.3 | -20.8 | -9.6 | 2.2 | -1.4 | -3.2 | -1.1 | |
| Total Common Equity | 2,037.8 | 1,965.2 | 2,123.4 | 2,089.9 | 1,616.0 | 1,502.3 | 1,377.2 | 1,263.7 | 1,198.3 | 660.2 | 579.9 | 508.3 | 464.7 | 390.9 | 323.2 | 274.3 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 2.5 | 2.5 | 2.5 | 2.5 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | 2.4 | |
| Retained Earnings | 706.6 | 710.0 | 674.7 | 690.2 | 714.0 | 747.0 | 768.4 | 807.8 | 825.0 | 817.8 | |
| Comprehensive Income | -33.0 | -32.6 | -105.4 | -139.4 | -62.4 | -91.8 | -69.5 | -53.1 | -84.7 | -48.8 | |
| Total Common Equity | 2,127.3 | 2,115.8 | 1,987.7 | 1,965.2 | 2,048.6 | 2,037.8 | 2,067.8 | 2,123.4 | 2,098.4 | 2,114.8 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 1,679.3 | 1,641.7 | 1,704.7 | 1,653.4 | 45.0 | 52.1 | 36.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 2,037.8 | 1,965.2 | 2,123.4 | 2,089.9 | 1,616.0 | 1,502.3 | 1,377.2 | 1,263.7 | 1,198.3 | 660.2 | 579.9 | 508.3 | 464.7 | 390.9 | 323.2 | 274.3 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 2,127.3 | 2,115.8 | 1,987.7 | 1,965.2 | 2,048.6 | 2,037.8 | 2,067.8 | 2,123.4 | 2,098.4 | 2,114.8 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -70.8 | 0.7 | -117.7 | -29.7 | -74.3 | 103.1 | 86.9 | 101.0 | 28.8 | 68.6 | 63.1 | 45.0 | 26.3 | 40.4 | 41.3 | 44.7 | 30.9 | |
| Depreciation & Amortization | 226.4 | 200.7 | 240.9 | 228.8 | 235.2 | 89.7 | 94.8 | 85.2 | 74.7 | 66.6 | 19.1 | 18.1 | 19.4 | 19.5 | 19.0 | 18.3 | 17.3 | |
| Stock-Based Compensation | 44.2 | 55.8 | 46.9 | 40.6 | 36.0 | 27.3 | 24.0 | 21.9 | 24.2 | 19.4 | 15.2 | 12.8 | 9.6 | 5.4 | 5.6 | 4.0 | 3.5 | |
| Change Working Capital | 4.9 | -90.0 | -2.6 | -135.6 | -303.7 | 15.0 | -17.0 | -111.6 | -25.4 | 55.9 | -8.8 | -25.8 | 3.4 | -4.9 | -2.4 | 9.9 | -20.0 | |
| Change In Accounts Receivable | 8.6 | 8.9 | -46.8 | 48.6 | -19.2 | 13.8 | 78.0 | -23.7 | -76.7 | -54.5 | 0.7 | -20.5 | 4.9 | 3.6 | -5.4 | 6.2 | -8.0 | |
| Change In Accounts Payable | -12.0 | 7.0 | 12.5 | -68.3 | 37.5 | 2.3 | -46.4 | -2.7 | 23.3 | 46.6 | -0.5 | 3.1 | -0.6 | 0.0 | -1.5 | 2.7 | -8.2 | |
| Change In Inventories | 91.1 | -26.3 | 16.8 | -6.1 | -201.1 | 20.8 | 19.2 | -25.0 | -21.8 | 181.7 | -5.5 | -8.3 | -3.8 | 2.3 | 4.6 | 3.2 | -3.7 | |
| Other Non-cash Items | 288.6 | 12.7 | 36.6 | 62.1 | 44.7 | 29.5 | 30.3 | -22.2 | 37.6 | -0.1 | 1.4 | 1.7 | 2.2 | 2.7 | 2.6 | 44.7 | 1.9 | |
| Cash from Operations | 254.2 | 0.0 | 0.0 | 166.2 | -62.1 | 267.5 | 222.8 | 101.9 | 160.2 | 154.4 | 89.9 | 54.9 | 60.6 | 64.0 | 66.3 | 64.5 | 33.1 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -15.7 | -3.4 | 35.3 | -15.5 | -23.8 | -33.0 | -21.4 | -39.5 | -17.1 | 7.2 | |
| Depreciation & Amortization | 54.3 | 52.4 | 49.7 | 49.4 | 53.0 | 55.7 | 55.3 | 55.5 | 57.2 | 58.4 | |
| Stock-Based Compensation | 0.0 | 15.2 | 14.5 | 12.2 | 12.5 | 11.8 | 0.0 | 11.6 | 10.7 | 10.9 | |
| Change Working Capital | -6.8 | -25.8 | -49.1 | -11.9 | -17.7 | -13.5 | 24.5 | 4.1 | 14.1 | -37.7 | |
| Change In Accounts Receivable | 4.9 | -12.7 | -5.7 | 22.4 | -35.3 | -18.2 | -7.3 | 14.0 | 5.5 | -3.7 | |
| Change In Accounts Payable | -16.3 | 0.0 | -17.7 | 32.1 | -8.6 | 11.7 | 4.1 | 5.3 | -3.3 | -18.2 | |
| Change In Inventories | 10.0 | -7.0 | -21.0 | -8.2 | 7.4 | -11.7 | 6.9 | 14.2 | 60.6 | 9.4 | |
| Other Non-cash Items | 28.8 | 18.2 | -39.2 | 17.1 | 16.2 | 15.1 | 23.6 | 14.0 | 46.0 | 8.9 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 91.3 | 35.2 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -97.3 | -88.0 | -79.4 | -83.9 | -99.3 | -81.2 | -100.4 | -106.0 | -100.8 | -79.7 | -24.6 | -13.9 | -17.6 | -19.5 | -20.3 | -15.8 | -23.2 | |
| Acquisitions | 0.8 | 0.0 | 0.0 | 0.0 | -1,844.2 | -14.5 | -8.4 | -76.1 | -1.3 | -162.4 | -2.6 | -27.8 | -1.0 | -1.1 | -1.1 | 0.0 | 0.0 | |
| Investments | 1.4 | 0.0 | 0.0 | 0.0 | -3.4 | -13.3 | -32.8 | -26.0 | -30.5 | -24.7 | -118.4 | -56.1 | -93.6 | -86.0 | -98.9 | -90.5 | -23.4 | |
| Sales of Investment | 1.8 | 0.0 | 0.5 | 4.2 | 36.4 | 18.0 | 28.9 | 41.3 | 15.4 | -5.2 | 158.5 | 83.1 | 89.4 | 92.3 | 77.8 | 44.4 | 64.7 | |
| Other Investing Activities | -0.7 | 0.0 | 0.0 | -8.3 | 1.0 | 0.2 | 14.6 | 0.0 | 13.8 | 5.2 | 3.3 | 3.6 | 1.0 | 1.1 | 1.2 | 16.2 | 1.5 | |
| Cash from Investing | -94.7 | 0.0 | 0.0 | -87.9 | -1,909.5 | -90.7 | -98.1 | -166.9 | -103.4 | -266.9 | 16.3 | -11.2 | -21.8 | -13.1 | -41.4 | -45.7 | 19.6 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -26.4 | -29.1 | -19.7 | -14.6 | -24.1 | -14.5 | -21.9 | -15.9 | -32.0 | -24.6 | |
| Acquisitions | 219.2 | 0.0 | 0.0 | 0.0 | 0.0 | -0.7 | 0.2 | 0.0 | 0.0 | 0.1 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.4 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 1.3 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.4 | 0.1 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -30.7 | -24.5 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -41.4 | 0.0 | 0.0 | -30.7 | -23.1 | -0.6 | -150.4 | 0.0 | 0.0 | -75.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 79.6 | 1,641.7 | -63.1 | 82.0 | 1,631.4 | -6.5 | 166.2 | 36.3 | 0.0 | 75.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 0.8 | 0.0 | 0.0 | 0.0 | 8.8 | 0.0 | 0.0 | 0.0 | 0.0 | 2.7 | 2.4 | 2.2 | 2.5 | 2.5 | 2.2 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -12.0 | -8.8 | -12.0 | -9.4 | 0.0 | 0.0 | 0.0 | -18.6 | -6.3 | -4.1 | -17.2 | -1.5 | -5.8 | -3.0 | 0.0 | -12.0 | -28.6 | |
| Dividends Paid | -11.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -3.3 | 0.0 | 0.0 | 0.0 | 1,651.3 | -16.3 | 150.3 | 7.7 | 14.3 | 32.0 | 17.3 | 24.4 | 22.7 | 26.7 | 19.4 | 14.1 | 5.8 | |
| Cash from Financing | -51.5 | 0.0 | 0.0 | -36.0 | 1,637.0 | -16.9 | 0.0 | -10.9 | 8.0 | -44.3 | 2.5 | 25.0 | 19.3 | 26.1 | 21.6 | 2.1 | -22.9 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.7 | -7.7 | |
| Debt Issued | 1,364.5 | -25.7 | -210.2 | -41.2 | -17.3 | -20.3 | -7.9 | -17.5 | 77.5 | 1.5 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.0 | 1.8 | |
| Repurchase of Common Stock | -8.8 | 0.0 | 0.0 | 0.0 | -12.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.5 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -11.5 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 1.3 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.8 | -6.4 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 106.8 | -0.6 | 54.3 | 45.4 | -344.0 | 156.7 | 127.4 | -76.1 | 54.7 | -155.0 | 108.9 | 60.4 | 49.8 | 79.1 | 47.3 | 20.7 | 27.6 | |
| Closing Cash Balance | 302.6 | 308.0 | 308.6 | 254.2 | 208.8 | 552.8 | 396.1 | 268.7 | 344.8 | 290.1 | 445.1 | 336.2 | 275.8 | 226.0 | 146.9 | 99.6 | 78.9 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 8.2 | -0.3 | 10.3 | -18.9 | -3.9 | 9.9 | 51.2 | -2.8 | 57.0 | 1.3 | |
| Closing Cash Balance | 308.0 | 299.7 | 300.0 | 289.7 | 308.6 | 312.5 | 302.6 | 251.4 | 254.2 | 197.2 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 156.9 | 91.8 | 124.7 | 72.5 | -161.5 | 186.4 | 122.4 | -4.1 | 59.4 | 74.7 | 65.4 | 40.9 | 43.0 | 44.5 | 46.0 | 48.7 | 9.9 | |
| Real Free Cash Flow | 112.7 | 36.0 | 77.8 | 32.0 | -197.5 | 159.0 | 98.4 | -26.0 | 35.2 | 55.4 | 50.1 | 28.1 | 33.5 | 39.1 | 40.4 | 44.6 | 6.5 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 36.0 | 27.6 | -10.8 | 36.7 | 13.6 | 21.6 | 62.5 | 26.9 | 59.3 | 10.6 | |
| Real Free Cash Flow | 36.0 | 12.4 | -25.3 | 24.5 | 1.1 | 9.8 | 62.5 | 15.3 | 48.6 | -0.3 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 4227.8 | 71 | 1703.4 |
| P/S | 1.4 | 3.3 | 67.9 |
| P/B | 1.5 | 2.6 | 25.8 |
| P/FCF | 65 | 23.4 | 396.3 |
| Market cap | $3.5 | $3.1 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 9 % | 0 % |
| Debt to Income | 186412.8 % | -309.9 % | 0 % |
| Debt to Free cash flow | 2865.7 % | 74.8 % | 0 % |
| Interest expense percentage | 155 % | 378.8 % | 38.7 % |
| Current ratio | 2.4 | 7.1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 0 % | 5.2 % | 0 % |
| ROA | 0 % | 4.8 % | 0 % |
| CapEx to Revenue | 4 % | 5.9 % | 10.6 % |
| RaD to Revenue | 0 % | 3.6 % | 0 % |
| ROEM | 148,724.5 | 125955.7 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 36.8 % | 41.5 % | 79.8 % |
| Operating margin | 2.8 % | 9.8 % | 29.6 % |
| Net margin | 0 % | 7 % | 27.3 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -1.3 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 24.7 mil | 19.4 mil |
| Employee count | 15.0 tis | 3.8 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
